Skip to content

AstraZeneca CEO stepping down

AstraZeneca P.L.C. chief executive officer David Brennan said Thursday he would retire June 1 after another difficult quarter for the pharmaceutical manufacturer. Based in the United Kingdom, AstraZeneca has its U.S. headquarters in Wilmington and a plant in Newark, Del.

Published